IOVA Iovance Biotherapeutics
- 12.500
- +0.720+6.11%
- 12.700
- +0.200+1.60%
Iovance Biotherapeutics News
Analysts Offer Insights on Healthcare Companies: Healthequity (HQY), Coya Therapeutics, Inc. (COYA) and Iovance Biotherapeutics (IOVA)
Iovance Biotherapeutics Analyst Ratings
Iovance Biotherapeutics (IOVA) Gets a Buy From Piper Sandler
Iovance Biotherapeutics Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Iovance Biotherapeutics (IOVA), Brainsway (BWAY) and Wave Life Sciences (WVE)
Analysts Have Conflicting Sentiments on These Healthcare Companies: Laboratory (LH), Apellis Pharmaceuticals (APLS) and Iovance Biotherapeutics (IOVA)
Positive Outlook for Iovance Biotherapeutics: Buy Rating Justified by Clinical Advancements and Strong Financials
Iovance Biotherapeutics Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Iovance Biotherapeutics, Maintains $32 Price Target
Wells Fargo Maintains Overweight on Iovance Biotherapeutics, Raises Price Target to $25
Iovance Biotherapeutics (IOVA) Receives a Buy From Truist Financial
Iovance Biotherapeutics: Strong Start for Amtagvi and Promising Global Expansion Underpin Buy Rating
HC Wainwright & Co. Reiterates Buy on Iovance Biotherapeutics, Maintains $32 Price Target
Iovance Biotherapeutics Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Iovance Biotherapeutics (IOVA) and Merit Medical Systems (MMSI)
Iovance Biotherapeutics (IOVA) Gets a Buy From Barclays
Iovance Biotherapeutics (IOVA) Receives a Buy From Piper Sandler
Iovance Biotherapeutics Analyst Ratings
Iovance Biotherapeutics Analyst Ratings
Analysts' Opinions Are Mixed on These Healthcare Stocks: Iovance Biotherapeutics (IOVA) and HealthStream (HSTM)
Analysis
Price Target
No Data
